Literature DB >> 8643100

The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H.

P N Boyd1, A C Lines, A K Patel.   

Abstract

A monoclonal human IgG1, Campath-1H, was digested with glycosidases to assess the effect of carbohydrate on the functional activities of an IgG1. Removal of the complete carbohydrate moiety abolished complement lysis activity and antibody-dependent cell-mediated cytotoxicity, but left antigen binding activity and protein A binding activity intact. Removal of terminal sialic acid residues through glycopeptidase F digestion was not found to affect any of the tested IgG activities. Removal of the majority of the galactose residues from desialylated Campath-1H was found to reduce but not abolish complement lysis activity. Other activities were not affected by degalactosylation. This indicates a rare separation of complement lysis activity and antibody-dependent cell-mediated cytotoxicity of IgG in the way they behave under controlled conditions. This paper underlines the overall importance of carbohydrate in IgG function and stresses the relative contributions of some of the carbohydrate residues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8643100     DOI: 10.1016/0161-5890(95)00118-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  61 in total

1.  Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314.

Authors:  Ralf Kircheis; Nicole Halanek; Iris Koller; Wolfgang Jost; Manfred Schuster; Gilbert Gorr; Klaus Hajszan; Andreas Nechansky
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

2.  Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay.

Authors:  Bhavin S Parekh; Elaine Berger; Sharon Sibley; Suntara Cahya; Liqun Xiao; Melinda Ann LaCerte; Peter Vaillancourt; Scott Wooden; Dennis Gately
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

Review 3.  The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.

Authors:  Sybille Böhm; Inessa Schwab; Anja Lux; Falk Nimmerjahn
Journal:  Semin Immunopathol       Date:  2012-03-22       Impact factor: 9.623

4.  Effects of statins on the immunoglobulin G glycome.

Authors:  Toma Keser; Frano Vučković; Clara Barrios; Jonas Zierer; Annika Wahl; Akintunde O Akinkuolie; Jerko Štambuk; Natali Nakić; Tamara Pavić; Josipa Periša; Samia Mora; Christian Gieger; Cristina Menni; Tim D Spector; Olga Gornik; Gordan Lauc
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-03-02       Impact factor: 3.770

5.  Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.

Authors:  Nicholas Veomett; Tao Dao; Hong Liu; Jingyi Xiang; Dmitry Pankov; Leonid Dubrovsky; Joseph A Whitten; Sun-Mi Park; Tatyana Korontsvit; Victoria Zakhaleva; Emily Casey; Michael Curcio; Michael G Kharas; Richard J O'Reilly; Cheng Liu; David A Scheinberg
Journal:  Clin Cancer Res       Date:  2014-05-21       Impact factor: 12.531

Review 6.  Modulating carbohydrate-protein interactions through glycoengineering of monoclonal antibodies to impact cancer physiology.

Authors:  Austin Wt Chiang; Shangzhong Li; Philipp N Spahn; Anne Richelle; Chih-Chung Kuo; Mojtaba Samoudi; Nathan E Lewis
Journal:  Curr Opin Struct Biol       Date:  2016-09-14       Impact factor: 6.809

7.  Post-translational modifications differentially affect IgG1 conformation and receptor binding.

Authors:  Damian Houde; Yucai Peng; Steven A Berkowitz; John R Engen
Journal:  Mol Cell Proteomics       Date:  2010-01-26       Impact factor: 5.911

8.  Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody.

Authors:  Shui-On Leung; Kai Gao; Guang Yu Wang; Benny Ka-Wa Cheung; Kwan-Yeung Lee; Qi Zhao; Wing-Tai Cheung; Jun Zhi Wang
Journal:  MAbs       Date:  2015       Impact factor: 5.857

9.  Glycan structure and serum half-life of recombinant CTLA4Ig, an immunosuppressive agent, expressed in suspension-cultured rice cells with coexpression of human β1,4-galactosyltransferase and human CTLA4Ig.

Authors:  Seung Hoon Kang; Hahn Sun Jung; Song Jae Lee; Cheon Ik Park; Sang Min Lim; Heajin Park; Byung Sun Kim; Kwang Heum Na; Gyeong Jin Han; Jae Woo Bae; Hyun Joo Park; Keuk Chan Bang; Byung Tae Park; Hye Seong Hwang; In-Soo Jung; Jae Il Kim; Doo Byung Oh; Dong Il Kim; Hirokazu Yagi; Koichi Kato; Dae Kyong Kim; Ha Hyung Kim
Journal:  Glycoconj J       Date:  2015-05-14       Impact factor: 2.916

10.  High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.

Authors:  Mohammad A Alsenaidy; Jae Hyun Kim; Ranajoy Majumdar; David D Weis; Sangeeta B Joshi; Thomas J Tolbert; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2013-09-24       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.